SAN DIEGO, Nov. 20, 2018 /PRNewswire/ -- Heron
Therapeutics, Inc. (NASDAQ: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by
developing best-in-class treatments to address some of the most important unmet patient needs, announced that Barry D. Quart,
Pharm.D., Chief Executive Officer of Heron Therapeutics, will participate in a fireside chat at the Evercore ISI HealthCONx
Conference on Tuesday, November 27, 2018, at 10:15 a.m. EST at the
Boston Harbor Hotel.
A live webcast of the event will be available on the Company's website at www.herontx.com in the Investor Resources section. A replay of the event will be archived on the site for
60 days.
About Heron Therapeutics, Inc.
Heron Therapeutics, Inc. is a commercial-stage biotechnology company focused on improving the lives of patients by developing
best-in-class treatments to address some of the most important unmet patient needs. Heron is developing novel, patient-focused
solutions that apply its innovative science and technologies to already-approved pharmacological agents for patients suffering
from cancer or pain.
For more information, visit www.herontx.com.
Forward-Looking Statements
This news release contains "forward-looking statements" as defined by the Private Securities Litigation Reform Act of 1995.
Heron cautions readers that forward-looking statements are based on management's expectations and assumptions as of the date of
this news release and are subject to certain risks and uncertainties that could cause actual results to differ materially,
including, but not limited to, risks and uncertainties identified in the Company's filings with the U.S. Securities and Exchange
Commission. Forward-looking statements reflect our analysis only on their stated date, and Heron takes no obligation to update or
revise these statements except as may be required by law.
Investor Relations and Media Contact:
David Szekeres
Senior VP, General Counsel, Business Development and Corporate Secretary
Heron Therapeutics, Inc.
dszekeres@herontx.com
858-251-4447
View original content:http://www.prnewswire.com/news-releases/heron-therapeutics-to-present-at-the-evercore-isi-healthconx-conference-300753893.html
SOURCE Heron Therapeutics, Inc.